Statistical Considerations for Clinical Development in China
View Presentation View Presentation
*William Wang, Merck Sharp &Dohme Ltd., China 


In recent years, there has been an increasing trend by multinational companies to shift global clinical trials to emerging regions such as China. This presentation will feature the current state of clinical trials in China as well as statistical considerations such as sample size requirements, statistical significance and regional consistency. Data management, reporting practices, and requirements will also be discussed.